IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex’s Fourth-Quarter Loss Widens

10:29 PM MST | February 10, 2010 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported a net loss of $2.8 million for the fourth quarter of 2009, compared with a net loss of about $1 million in the fourth quarter of 2008. Net sales decreased by nearly 10%, to $57.9 million. The fall in sales, was mainly due to lower volumes of an active pharmaceutical ingredient (API) that utilizes Cambrex’s polymeric drug delivery technology, lower sales of two APIs manufactured under long-term supply agreements and lower custom development revenues, Cambrex says. Volumes of a feed additive for which a contract expired...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa